• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
Bioxcel Therap released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 98K (forecast USD 216.67K), actual EPS USD -2.1774 (forecast USD -1.34)
04:00
Bioxcel Therap released FY2025 9 Months Earnings on November 12 (EST), actual revenue USD 386K, actual EPS USD -6.1244
04:00
Oct16
Selvaraju focuses on healthcare stocks such as Bioxcel Therapeutics
13:02
Sep10
BioXcel Therapeutics Announces Positive Results for BXCL501 Phase 3 Trial
10:32
Aug26
BioXcel Therapeutics to Announce Preliminary Results of Serenity Phase 3 Safety Trial
20:01
Aug18
BioXcel Therapeutics Inc. Launches ATM Program to Sell Up to $80 Million in Common Stock
21:16

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 98 K, Net Income -30.91 M, EPS -2.1774

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 120 K, Net Income -19.19 M, EPS -2.4463

May12
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 168 K, Net Income -7.254 M, EPS -1.5006

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
25.440
+276.44%
+18.682
SMX
331.980
+135.45%
+190.980
WHLR
6.410
+97.84%
+3.170
GURE
8.190
+72.78%
+3.450
DBRG
14.120
+45.27%
+4.400
TORO
5.800
+40.44%
+1.670
TDIC
0.3937
+40.21%
+0.113
LICN
4.070
+38.91%
+1.140
SPHL
4.530
+36.04%
+1.200
ALMS
11.120
+33.98%
+2.820
View More